EN
HI
CORONA Remedies Share price
CORONA
2142.6
23.20 (-1.07%)NSE
BSE
Last updated on 21 Aug, 2026 | 15:31 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
CORONA Remedies share price chart
CORONA Remedies Share Key Metrics
Volume
12564.00
Market Cap
13104.16 CR
LTQ@LTP
11@2142.60
ATP
2140.26
Var Margin
13.2 %
Circuit Range
1732.7-2598.9
Delivery %
42.44 %
Value
2.69 CR
ASM/GSM
No
Market Lot
1
Summary
CORONA stock price is ₹2142.6 as of 22 Aug, 2026. The stock intraday movement has stayed between ₹2121.10 and ₹2179.90, while CORONA Remedies share price 52 week high low is ₹1336.60 & ₹2270.10.
In terms of trading activity, CORONA share price has recorded a volume of 12,564 shares. The CORONA Remedies has a market cap of ₹61160088. The stock’s Average Traded Price (ATP) stands at ₹2140.26, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 11 @ ₹2142.60.
The CORONA Remedies upper circuit limit is ₹2598.90 & The CORONA Remedies lower circuit limit is ₹1732.70, with a Value of ₹2.69 CR. The Delivery Percentage for the day is 42.44%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
CORONA Remedies Resistance and Support
Pivot 2161.17
Resistance
First Resistance
2197.44
Second Resistance
2229.07
Third Resistance
2265.34
Support
First Support
2129.54
Second Support
2093.27
Third Support
2061.64
CORONA Remedies Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-11 | Audited Results & Final Dividend |
| 2026-02-02 | Quarterly Results |
| 2026-01-02 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-06-19 | 2026-06-19 | View More |
CORONA Remedies News
Corona Remedies Ltd - 544644 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Corona Remedies officials will attend an in-person investor conference on August 26, 2026, in Ahmedabad. The meeting is organized by Phillip Capital PCG, with discussions based on publicly available information.
Aug 20 2026 17:18:36
Corona Remedies Ltd - 544644 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Corona Remedies Ltd officials will participate in investor conferences hosted by Emkay Global and Equirus on August 13 and 14, 2026, respectively. These in-person meetings in Mumbai will involve discussions based on publicly available information.
Aug 10 2026 11:20:26
Corona Remedies Ltd - 544644 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Corona Remedies announced the availability of the audio recording for its Q1 FY27 earnings conference call on its website. This recording provides insights into discussions with analysts and investors on the unaudited financial results for the quarter ended June 30, 2026.
Aug 03 2026 16:20:54
Corona Remedies Ltd - 544644 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Corona Remedies delivered strong Q1 FY27 results with revenue growing 21.9% YoY to Rs.422.4 Cr and PAT increasing 30.1% YoY to Rs.60.1 Cr. The company also inaugurated a new EU-GMP approved Female Hormone Manufacturing Facility in Ahmedabad.
Jul 31 2026 17:42:50
Corona Remedies Ltd - 544644 - Board Meeting Outcome for Outcome Of Board Meeting
Corona Remedies reported Q1 FY27 revenue of ₹422.4 cr, up 21.9% YoY, and net profit of ₹60.1 cr, up 30.1% YoY. This growth was supported by brand-building efforts and the inauguration of an EU-GMP approved Female Hormone Manufacturing Facility in Ahmedabad on June 30, 2026.
Jul 31 2026 17:20:17
Read More
CORONA Remedies Management
| Name | Position |
|---|---|
| Kirtikumar Laxmidas Mehta | Chairman |
| Niravkumar Kirtikumar Mehta | Managing Director & Chief Executive Officer |
CORONA Remedies Similar Stocks
Vijaya Diagnostic Centre Ltd.
1504.40
6.00 (0.40%)
Rainbow Children's Medicare Ltd.
1433.20
-20.30 (1.40%)
Marksans Pharma Ltd.
321.30
0.45 (0.14%)
Jubilant Pharmova Ltd.
880.35
9.30 (1.07%)
Sudeep Pharma Ltd.
1111.80
4.00 (0.36%)
Alivus Life Sciences Ltd.
1350.90
-19.10 (1.39%)
Molbio Diagnostics Ltd.
1098.45
61.80 (5.96%)
Viyash Scientific Ltd.
275.95
10.10 (3.80%)
Akums Drugs & Pharmaceuticals Ltd.
750.00
-2.90 (0.39%)
CORONA Remedies FAQs
The Buying Price of CORONA Remedies share is 2142.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy CORONA Remedies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for CORONA Remedies, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of CORONA Remedies shares is 66.51. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio CORONA Remedies shares is 16.4. Useful to assess the stock's value relative to its book value.
To assess CORONA Remedies’s valuation compare Sector P/E, P/B which are 69.06 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of CORONA Remedies is 13104.16 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of CORONA Remedies share price is 2270.10 & 1336.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
CORONA Remedies belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in CORONA
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC